Trial · NCT01460290
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Depressive Symptoms as Measured by the Hamilton Depression Rating Scale (HAM-D) | Asenapine | Baseline HAM-D | 17.5 | Standard Deviation 4.8 | units on a scale |
| Change in Depressive Symptoms as Measured by the Hamilton Depression Rating Scale (HAM-D) | Asenapine | 12 Week HAM-D | 10.3 | Standard Deviation 6.3 | units on a scale |
| Change in Manic Symptoms as Measured by the Young Mania Rating Scale (YMRS) | Asenapine | Baseline YMRS | 27.9 | Standard Deviation 4.4 | units on a scale |
| Change in Manic Symptoms as Measured by the Young Mania Rating Scale (YMRS) | Asenapine | 12 Week YMRS | 18.1 | Standard Deviation 14.2 | units on a scale |
| Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP) | Asenapine | Baseline Overall Severity | 4.4 | Standard Deviation 1.0 | units on a scale |
| Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP) | Asenapine | 12 Week Overall Severity | 2.2 | Standard Deviation 1.0 | units on a scale |
| Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP) | Asenapine | Baseline Mania Severity | 2.7 | Standard Deviation 1.7 | units on a scale |
| Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP) | Asenapine | 12 Week Mania Severity | 1.9 | Standard Deviation 1.1 | units on a scale |
| Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP) | Asenapine | Baseline Depression Severity | 3.6 | Standard Deviation 1.5 | units on a scale |
| Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP) | Asenapine | 12 Week Depression Severity | 1.7 | Standard Deviation 0.7 | units on a scale |
| Change in Perception of Physical Health as Measured by the Short Form General Health Survey (SF-12) | Asenapine | Baseline on Physical Health Subscale of SF-12 | 46.8 | Standard Deviation 11.3 | units on a scale |
| Change in Perception of Physical Health as Measured by the Short Form General Health Survey (SF-12) | Asenapine | 12 week on Physical Health Subscale of SF-12 | 46.4 | Standard Deviation 12.1 | units on a scale |
| Change in Perception of Mental Health as Measured by the Short Form General Health Survey (SF-12) | Asenapine | Baseline Mental Health Subscore of SF-12 | 38.7 | Standard Deviation 15.3 | units on a scale |
| Change in Perception of Mental Health as Measured by the Short Form General Health Survey (SF-12) | Asenapine | 12 Week Mental Health Subscore of SF-12 | 43.1 | Standard Deviation 13.1 | units on a scale |
| Change in Depressive Symptoms as Measured by the Montgomery Asberg Depression Rating Scale (MADRS) | Asenapine | Baseline MADRS | 27.9 | Standard Deviation 4.4 | units on a scale |
| Change in Depressive Symptoms as Measured by the Montgomery Asberg Depression Rating Scale (MADRS) | Asenapine | 12 Week MADRS | 18.1 | Standard Deviation 14.2 | units on a scale |
| Change in Bipolar Disorder Symptoms as Measured by the Brief Psychiatric Rating Scale (BPRS) | Asenapine | Baseline BPRS | 35.1 | Standard Deviation 9.2 | units on a scale |
| Change in Bipolar Disorder Symptoms as Measured by the Brief Psychiatric Rating Scale (BPRS) | Asenapine | 12 Week BPRS | 28.6 | Standard Deviation 9.4 | units on a scale |
| Change in Cognitive Status as Measured by the Stroop Task | Asenapine | Baseline Word Subscale | 75.7 | Standard Deviation 12.0 | T-Score |
| Change in Cognitive Status as Measured by the Stroop Task | Asenapine | 12 Week Word Subscale | 75.9 | Standard Deviation 11.5 | T-Score |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01460290/results